Human immunodeficiency virus type 1 envelope-mediated neuropathogenesis: Targeted gene delivery by a Sindbis virus expression vector

Virology

Volumn 309, Issue 1, 2003, Pages 61-74

  Van Marle, Guido ^a   Ethier, Julie ^a   Silva, Claudia ^a   Mac Vicar, Brian A ^a   Power, Christopher ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Astrocytes; Brain; HIV associated dementia; HIV 1; HIV 1 envelope protein gp120; Microglia; Neuron; Neuronal death; Sindbis virus; Tropism

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUROTOXIN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR; CELL LOSS; CELL TYPE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINDBIS VIRUS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS PATHOGENESIS; VIRUS STRAIN;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; SINDBIS VIRUS; VECTORS;

EID: 0037466627     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00139-3     Document Type: Article

References (79)

1. Abacioglu Y.H., Fouts T.R., Laman J.D., Claassen E., Pincus S.H., Moore J.P., Roby C.A., Kamin-Lewis R., Lewis G.K. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retroviruses. 10:(4):1994;371-381.
2. Agapov E.V., Frolov I., Lindenbach B.D., Pragai B.M., Schlesinger S., Rice C.M. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc. Natl. Acad. Sci. USA. 95:(22):1998;12989-12994.
3. Altman-Hamamdzic S., Groseclose C., Ma J.X., Hamamdzic D., Vrindavanam N.S., Middaugh L.D., Parratto N.P., Sallee F.R. Expression of beta-galactosidase in mouse brain utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system . Gene Ther. 4:(8):1997;815-822.
4. Araque A., Sanzgiri R.P., Parpura V., Haydon P.G. Calcium elevation in astrocytes causes an NMDA receptor-dependent increase in the frequency of miniature synaptic currents in cultured hippocampal neurons. J. Neurosci. 18:(17):1998;6822-6829.
5. Armstrong J.N., MacVicar B.A. Theta-frequency facilitation of AMPA receptor-mediated synaptic currents in the principal cells of the medial septum. J. Neurophysiol. 85:(4):2001;1709-1718.
6. Bagasra O., Lavi E., Bobroski L., Khalili K., Pestaner J.P., Tawadros R., Pomerantz R.J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals identification by the combination of in situ polymerase chain reaction and immunohistochemistry . AIDS. 10:(6):1996;573-585.
7. Bagetta G., Corasaniti M.T., Aloe L., Berliocchi L., Costa N., Finazzi-Agro A., Nistico G. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc. Natl. Acad. Sci. USA. 93:(2):1996;928-933.
8. Bansal A.K., Mactutus C.F., Nath A., Maragos W., Hauser K.F., Booze R.M. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res. 879:(1-2):2000;42-49.
9. Bennett B.A., Rusyniak D.E., Hollingsworth C.K. HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Res. 705:(1-2):1995;168-176.
10. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFα amplification by microglia triggers neurotoxicity . Nat. Neurosci. 4:(7):2001;702-710.
11. Bjorklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3:(6):2000;537-544.
12. Boutet A., Altmeyer R., Hery C., Tardieu M. Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages. AIDS. 14:(17):2000;2687-2697.
13. Bredenbeek P.J., Frolov I., Rice C.M., Schlesinger S. Sindbis virus expression vectors packaging of RNA replicons by using defective helper RNAs . J. Virol. 67:(11):1993;6439-6446.
14. Chen P., Mayne M., Power C., Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production. Implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272:(36):1997;22385-22388.
15. Corasaniti M.T., Maccarrone M., Nistico R., Malorni W., Rotiroti D., Bagetta G. Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo. J. Neurochem. 79:(1):2001;1-8.
16. Corder E.H., Robertson K., Lannfelt L., Bogdanovic N., Eggertsen G., Wilkins J., Hall C. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat. Med. 4:(10):1998;1182-1184.
17. Corley S.M., Ladiwala U., Besson A., Yong V.W. Astrocytes attenuate oligodendrocyte death in vitro through an α(6) integrin-laminin-dependent mechanism. Glia. 36:(3):2001;281-294.
18. Daadi M.M., Weiss S. Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain. J. Neurosci. 19:(11):1999;4484-4497.
19. D'Apuzzo M., Mandolesi G., Reis G., Schuman E.M. Abundant GFP expression and ltp in hippocampal acute slices by in vivo injection of sindbis virus. J. Neurosphysiol. 86:(2):2001;1037-1042.
20. Dryga S.A., Dryga O.A., Schlesinger S. Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells the importance of a mutation in the nsP2 gene . Virology. 228:(1):1997;74-83.
21. Ehrengruber M.U., Lundstrom K., Schweitzer C., Heuss C., Schlesinger S., Gahwiler B.H. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc. Natl. Acad. Sci. USA. 96:(12):1999;7041-7046.
22. Frolov I., Agapov E., Hoffman T.A. Jr., Pragai B.M., Lippa M., Schlesinger S., Rice C.M. Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J. Virol. 73:(5):1999;3854-3865.
23. Frolov I., Hoffman T.A., Pragai B.M., Dryga S.A., Huang H.V., Schlesinger S., Rice C.M. Alphavirus-based expression vectors strategies and applications . Proc. Natl. Acad. Sci. USA. 93:(21):1996;11371-11377.
24. Gardner J.P., Frolov I., Perri S., Ji Y., MacKichan M.L., zur Megede J., Chen M., Belli B.A., Driver D.A., Sherrill S., Greer C.E., Otten G.R., Barnett S.W., Liu M.A., Dubensky T.W., Polo J.M. Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein. J. Virol. 74:(24):2000;11849-11857.
25. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain correlations with dementia . Ann. Neurol. 38:(5):1995;755-762.
26. Gonzalez-Scarano F., Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22:1999;219-240.
27. Griffin D.E., Hardwick J.M. Regulators of apoptosis on the road to persistent alphavirus infection. Annu. Rev. Microbiol. 51:1997;565-592.
28. Gwag B.J., Kim E.Y., Ryu B.R., Won S.J., Ko H.W., Oh Y.J., Cho Y.G., Ha S.J., Sung Y.C. A neuron-specific gene transfer by a recombinant defective Sindbis virus. Brain Res. Mol. Brain Res. 63:(1):1998;53-61.
29. Hanna Z., Kay D.G., Cool M., Jothy S., Rebai N., Jolicoeur P. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol. 72:(1):1998;121-132.
30. Hanna Z., Kay D.G., Rebai N., Guimond A., Jothy S., Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell. 95:(2):1998;163-175.
31. Hanna Z., Weng X., Kay D.G., Poudrier J., Lowell C., Jolicoeur P. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J. Virol. 75:(19):2001;9378-9392.
32. Hofmann W., Schubert D., LaBonte J., Munson L., Gibson S., Scammell J., Ferrigno P., Sodroski J. Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73:(12):1999;10020-10028.
33. Imai Y., Ibata I., Ito D., Ohsawa K., Kohsaka S. A novel gene Iba-1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224:(3):1996;855-862.
34. Ito D., Imai Y., Ohsawa K., Nakajima K., Fukuuchi Y., Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba-1. Brain Res. Mol. Brain Res. 57:(1):1998;1-9.
35. Johnston J.B., Silva C., Power C. Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection induction of matrix metalloproteinases and neuronal injury . J. Virol. 76:(6):2002;2622-2633.
36. Johnston J.B., Zhang K., Silva C., Shalinsky D.R., Conant K., Ni W., Corbett D., Yong V.W., Power C. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann. Neurol. 49:(2):2001;230-241.
37. Jolicoeur P., Laperriere A., Beaulieu N. Efficient production of human immunodeficiency virus proteins in transgenic mice. J. Virol. 66:(6):1992;3904-3908.
38. Kamps C.A., Lin Y.C., Wong P.K. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuL V-TB. Virology. 184:(2):1991;687-694.
39. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410:(6831):2001;988-994.
40. Kaul M., Lipton S.A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA. 96:(14):1999;8212-8216.
41. Keppler O.T., Yonemoto W., Welte F.J., Patton K.S., Iacovides D., Atchison R.E., Ngo T., Hirschberg D.L., Speck R.F., Goldsmith M.A. Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 75:(17):2001;8063-8073.
42. Lewis A.D., Johnson P.R. Developing animal models for AIDS research - progress and problems. Trends Biotechnol. 13:(4):1995;142-150.
43. Li Y., Kappes J.C., Conway J.A., Price R.W., Shaw G.M., Hahn B.H. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue identification of replication-competent and -defective viral genomes . J. Virol. 65:(8):1991;3973-3985.
44. Lundstrom K. Alphaviruses as tools in neurobiology and gene therapy. J. Recept. Signal Transduct. Res. 19:(1-4):1999;673-686.
45. Lynch W.P., Robertson S.J., Portis J.L. Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. J. Virol. 69:(3):1995;1408-1419.
46. Lynch W.P., Sharpe A.H. Differential glycosylation of the Cas-Br-E env protein is associated with retrovirus-induced spongiform neurodegeneration. J. Virol. 74:(3):2000;1558-1565.
47. Mariani R., Rutter G., Harris M.E., Hope T.J., Krausslich H.G., Landau N.R. A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74:(8):2000;3859-3870.
48. McArthur J.C., Hoover D.R., Bacellar H., Miller E.N., Cohen B.A., Becker J.T., Graham N.M., McArthur J.H., Selnes O.A., Jacobson L.P., et al. Dementia in AIDS patients incidence and risk factors. Multicenter AIDS Cohort Study . Neurology. 43:(11):1993;2245-2252.
49. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., Perno C.F. Oxidative stress and neuroAIDS triggers, modulators and novel antioxidants . Trends Neurosci. 24:(7):2001;411-416.
50. Morrow W.J., Wharton M., Lau D., Levy J.A. Small animals are not susceptible to human immunodeficiency virus infection. J. Gen. Virol. 68:(Pt 8):1987;2253-2257.
51. Nath A., Conant K., Chen P., Scott C., Major E.O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem. 274:(24):1999;17098-17102.
52. Nuovo G.J., Gallery F., MacConnell P., Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 144:(4):1994;659-666.
53. Parpura V., Basarsky T.A., Liu F., Jeftinija K., Jeftinija S., Haydon P.G. Glutamate-mediated astrocyte-neuron signalling. Nature. 369:(6483):1994;744-7470.
54. Persidsky Y., Limoges J., McComb R., Bock P., Baldwin T., Tyor W., Patil A., Nottet H.S., Epstein L., Gelbard H., Flanagan E., Reinhard J., Pirruccello S.J., Gendelman H.E. Human immunodeficiency virus encephalitis in SCID mice. Am. J. Pathol. 149:(3):1996;1027-1053.
55. Power C., Johnson R.T. Neuroimmune and neurovirological aspects of human immunodeficiency virus infection. Adv. Virus Res. 56:2001;389-433.
56. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., Trapp B.D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia Alterations of the blood-brain barrier . Ann. Neurol. 34:(3):1993;339-350.
57. Power C., McArthur J.C., Nath A., Wehrly K., Mayne M., Nishio J., Langelier T., Johnson R.T., Chesebro B. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J. Virol. 72:(11):1998;9045-9053.
58. Quasney M.W., Zhang Q., Sargent S., Mynatt M., Glass J., McArthur J. Increased frequency of the tumor necrosis factor-α-308 a allele in adults with human immunodeficiency virus dementia . Ann. Neurol. 50:(2):2001;157-162.
59. Schlesinger S. Alphavirus expression vectors. Adv. Virus Res. 55:2000;565-577.
60. Schlesinger S., Dubensky T.W. Alphavirus vectors for gene expression and vaccines. Curr. Opin. Biotechnol. 10:(5):1999;434-439.
61. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., Honore T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline a neuroprotectant for cerebral ischemia . Science. 247:(4942):1990;571-574.
62. Snyder E.Y., Deitcher D.L., Walsh C., Arnold-Aldea S., Hartwieg E.A., Cepko C.L. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell. 68:(1):1992;33-51.
63. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:(2):1991;173-182.
64. Strauss J.H., Strauss E.G. The alphaviruses gene expression, replication, and evolution . Microbiol. Rev. 58:(3):1994;491-562.
65. Strelow L.I., Janigro D., Nelson J.A. The blood-brain barrier and AIDS. Adv. Virus Res. 56:2001;355-388.
66. Thompson K.A., McArthur J.C., Wesselingh S.L. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 49:(6):2001;745-752.
67. Toggas S.M., Masliah E., Rockenstein E.M., Rall G.F., Abraham C.R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:(6459):1994;188-193.
68. Torres-Munoz J., Stockton P., Tacoronte N., Roberts B., Maronpot R.R., Petito C.K. Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J. Neuropathol. Exp. Neurol. 60:(9):2001;885-892.
69. Trillo-Pazos G., Bentsman G., Chao W., Sharer L., Morgello S., Volsky D.J. 4th International Conference on Neurovirology/10th Conference on Neuroscience of HIV Infection, Dusseldorf. J. Neurovirol. 8:(Suppl. 1):2002;23.
70. Tyor W.R., Power C., Gendelman H.E., Markham R.B. A model of human immunodeficiency virus encephalitis in SCID mice. Proc. Natl. Acad. Sci. USA. 90:(18):1993;8658-8662.
71. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:(3):1970;485-493.
72. van Rij R.P., Portegies P., Hallaby T., Lange J.M., Visser J., Husman A.M., van't Wout A.B., Schuitemaker H. Reduced prevalence of the CCR5 Δ32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. J. Infect. Dis. 180:(3):1999;854-857.
73. Vecil G.G., Larsen P.H., Corley S.M., Herx L.M., Besson A., Goodyer C.G., Yong V.W. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 61:(2):2000;212-224.
74. Wahlfors J.J., Zullo S.A., Loimas S., Nelson D.M., Morgan R.A. Evaluation of recombinant alphaviruses as vectors in gene therapy. Gene Ther. 7:(6):2000;472-480.
75. Wei P., Garber M.E., Fang S.M., Fischer W.H., Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:(4):1998;451-462.
76. Weiss S., Hochman D., MacVicar B.A. Repeated NMDA receptor activation induces distinct intracellular calcium changes in subpopulations of striatal neurons in vitro. Brain Res. 627:(1):1993;63-71.
77. Wesselingh S.L., Thompson K.A. Immunopathogenesis of HIV-associated dementia. Curr. Opin. Neurol. 14:(3):2001;375-379.
78. Wong E.H., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:(18):1986;7104-7108.
79. Zhang K., Hawken M., Rana F., Welte F.J., Gartner S., Goldsmith M.A., Power C. Human immunodeficiency virus type 1 clade A and D neurotropism molecular evolution, recombination, and coreceptor use . Virology. 283:(1):2001;19-30.